A natural treatment for skin cancer

Skin cancer occurs when cells begin to multiply abnormally in their mutated form. Any abnormal growth of skin cells is called skin cancer, but only two types are malignant. Skin cancer can arise from moles that also represent changes in the skin. Skin cancer can be recognized in three basic types: melanoma, basal cell carcinoma, and squamous cell carcinoma.

Methods of treating skin cancer naturally.

The treatment of this disease has several methods in its basic medical form, such as surgical therapy, radiation, chemotherapy, photodynamic therapy, and biological therapy that strengthen the immune system’s action. The fact is that most of these therapies disrupt the patient’s immune system and create many side effects that are sometimes stronger than the effects of the disease itself. For this reason, natural therapy for skin cancer is recommended.
tumori kože pregled kod doktora

Black raspberry seed oil

Black raspberry seed oil is too rich in antioxidants and compounds that effectively act on cancer.
Black raspberry seeds are somewhat different because they kill cancer and boost the activity of the immune system. This property makes raspberry seed oil a potent alternative medicine and potent cancer prevention.

Eggplant extract

Eggplant extract and its cream containing 10% solasodine glycosides or so-called BEC cream is a clinically proven effective treatment for basal cell carcinoma, squamous cell carcinoma, and keratosis.
Since 1825, BEC has been an excellent means of combating malignant and benign skin tumors. Extracts of eggplant, tomato, cucumber, paprika, and tobacco are included in this cream.

Myrtle oil

Myrtle oil is used to treat various ailments. One gram of myrtle oil was paid for with one gram of gold at one point throughout history.
Research on this oil is limited, but there are two studies in which it has been proven that this oil destroys cancer cells. In these studies, its effectiveness against prostate cancer, breast cancer, and also against various forms of skin cancer has been proven.
Myrtle oil is generally safe for all skin types. It can be mixed with coconut oil and applied directly to tumors for sensitive skin.

Incense oil

ulje tamjana

Incense oil has been used for thousands of years to treat various diseases and disorders. Several pervasive clinical studies confirm its healing properties in breast cancer and various skin cancer types.
There are about 17 active ingredients in incense oil, and scientists still cannot confirm with certainty who is responsible for destroying which type of tumor. Incense oil can be a key ingredient in a long-term anti-cancer drug.
For topical application, take about 5 ml of incense oil, myrtle oil, and black raspberry seed oil and combine them with about 15 grams of natural eggplant cream or oral use with about 10 grams of eggplant extract. You can add 2-3 drops of lavender essential oil to this mixture. Apply the cream or take oral ingredients twice a day for your superficial or internal tumors.

Supplements that people with skin cancer should use are:

Vitamin D is one of the proven good vitamins that destroys cancer and is obtained by spending time in the sun. Spending time in the sun and taking vitamin D3 will strengthen the immune system, which will start destroying cancer.
The pancreatic enzyme or pancreatin is taken between meals and becomes a proteolytic enzyme. This enzyme increases the production of protease enzymes to break down proteins. This enzyme is released into the bloodstream, and it affects the protein coat of cancer by directly breaking it down. In this way, the protease helps the immune system fight cancer and destroy it because due to the very thick protein coat, the cells of the immune system cannot damage the cancer cells.
Probiotics help the immune system because 80% of the immune system is in the intestines. For that reason, it is necessary to maintain the intestines. You will build a healthy bacterial culture in your intestines by taking probiotics.
Selenium has proven to reduce the possibility of the death of people with skin cancer by 50%, and consumption reduces the size of malignancy in the body by 37%.
Curcumin has been proven to be good anti-cancer preparation. Curcumin effectively kills cancer cells and reduces cancer growth. Studies have shown that it is effective against breast cancer, bowel cancer, stomach cancer, and skin cancer.

Melanoma skin cancer treatment prognosis

Melanoma  (lat. melanoma; ICD-10: C34) is a malignant tumor that develops due to melanocyte skin cells’ malignant transformation. These cells are of the embryonic origin of the neural crest. Melanomas, in most cases, occur on the skin but can occur anywhere else where neural crest cells migrate during embryonic development, such as the gastrointestinal tract or the brain.

Melanoma predominantly affects adults, with a peak incidence in the fourth decade of life, and there is no significant difference in prevalence between the sexes. The risk of developing the second primary melanoma after the first diagnosis is 3-5%.

Melanoma is a growing problem as more and more people are affected. The incidence is estimated to grow by almost 6% per year.

Melanoma is less common than other types of skin cancer. However, it is much more dangerous if it is not found early. It causes the majority (75%) deaths associated with skin tumors (48,000 deaths per year). Worldwide, 160,000 new cases of melanoma are diagnosed annually. Currently, for example, in the U.S., 1 in 50 whites, 1 in 1,000 blacks, and 1 in 200 Hispanics develop melanoma at some point in their lives.

Similarly, international white populations in Australia, New Zealand, and South Africa have the highest incidences, while Asian populations in Hong Kong, Singapore, China, India, and Japan have low incidence rates. This all together suggests that whites in sunny areas have a higher risk of developing melanoma.

Melanoma risk factors

melanoma malignant tumor

A positive family history exists in 5-10% of patients; in cases where one relative suffers from melanoma, the risk increases 2.2-fold.

Blue eyes, red hair, pale complexion; skin reaction to the sun (easily gets sunburns); benign and/or dysplastic melanocyte nevi (the number has a better correlation than size); immunosuppressive conditions (transplant patients, hematological malignancies) – all these personal characteristics carry a higher risk.

Also,  sun exposure throughout life – often exposure to UVB and UVA radiation also carries a higher risk (recent evidence suggests that the risk of melanoma is higher in people who use sunscreen – since it blocks UVB radiation more, people who use sunscreen may be more exposed to UVA radiation than the general population, with the proviso that these people must be exposed to the sun more than the general population); small latitude, number of burns; use of solarium.

Atypical mole syndrome (formerly called BK mole syndrome, dysplastic nevus syndrome, familial atypical multiple melanoma mole) – over 10 years, the risk of developing melanoma is 10.7% compared to 0.62% of control; higher risk of melanoma depending on the number of affected family members (almost 100% risk if 2 or more relatives have dysplastic nevi and melanoma).

Pathophysiology of melanoma

Some scientists suggest that benign melanocyte nevi markers of melanoma risk are not direct precursors; however, dysplastic nevi are believed to degenerate over time into melanoma. Lentigo maligna is believed to be a preinvasive precursor of lentigo malignant melanoma, and that at least 5% of lentigo maligna progresses to malignancy.

Classification of melanoma

Melanoma is classified into 4 main types according to the growth pattern. These are superficial spreading melanoma, nodular melanoma, lentigo malignant melanoma, and acral lentiginous melanoma. Other more unusual types include mucosal lentiginous melanoma, desmoplastic melanoma, and verrucous melanoma.

Superficially spreading melanoma

 Superficially spreading melanoma
Superficially spreading melanoma

Superficially spreading melanoma makes up about 70% of all melanoma. Histologically, characteristic cells are present in nests along the dermo-epidermal junction and migrate to the stratum granulosum or stratum corneum. These cells can invade the papillary dermis with inflammatory lymphocytic infiltrate.

Clinically, these superficially spreading melanomas develop from pre-existing dysplastic nevi. Typically, the lesion changes slowly over several months to years. They are usually flat but can become irregular and elevated at later stages. The lesions are average 2 cm in diameter, with zones of different colors and peripheral protrusions, indentations, or both.

Nodular melanoma

Nodular melanoma cancer
Nodular melanoma

Nodular melanoma is characterized by extensive vertical growth into the dermis with a minimal radial component. They make up approximately 15-30% of melanoma diagnoses. These are tumors typically blue-black but may lack pigment in some circumstances. They can occur de novo without pre-existing lesions.

Lentigo malignant melanoma

Lentigo malignant melanoma

Lentigo malignant melanoma represents 4-10% of all melanomas. At the cellular level, dermal and epidermal changes from sun exposure must be present. Histologically, we find irregularly shaped hyperchromatic cells that form spindle formations. The epidermis is atrophic, while the dermis contains solar elastosis with chronic inflammatory infiltrates. From a clinical standpoint, lentigo malignant melanomas are usually larger than 3 cm, flat, darkened, and begin as small mottled lesions.

They occur in areas exposed to the sun (e.g., the face and neck of the elderly). Significant edge irregularities are present. Lentigo malignant melanoma usually develops within the Hutchinson melanocyte spot (lentigo maligna). When tumor thickness and location are taken into account, the prognosis for these melanomas is probably not worse than for other subtypes.

Acral lentiginous melanoma

Acral lentiginous melanoma
Acral lentiginous melanoma

Acral lentiginous melanoma makes up 2-8% of all melanoma in whites and 35-60% of all melanoma in dark-skinned individuals. Cellular proliferation is present along the dermal-epidermal border with microinvasion into the papillary dermis. The cells have increased melanin granules production, which fills their dendritic extensions.

Acral lentiginous melanoma occurs on the palms of the hands, under the nail bed, and on the feet’ soles. They can appear on the palms and soles of the feet as flat, ocher, or brown spots with irregular edges. Sublingual lesions may be brown or black, with ulcerations in later stages. There is no correlation with a worse prognosis for these lesions when tumor thickness is considered.

Desmoplastic melanomas

 Desmoplastic melanomas
Desmoplastic melanoma

Desmoplastic melanomas makeup approximately 1% of melanoma cases and tend to perineural invasion, especially in the head and neck. They are more prone to local recurrence but have a lower incidence of regional metastases.

Symptoms of melanoma

Typically, melanoma lesions are irregular contours and pigmentation. Macular areas correlate with the radial growth phase, while elevated areas usually correspond to nodular aggregates of malignant cells in the vertical growth phase.

Patients usually present with skin lesions that have changed in size, color, contour, or configuration. The acronym “ABCDE” is a feature of the international awareness campaign and can be used to remember characteristics that suggest malignant melanoma.

Lesions may itch, bleed, ulcerate, or develop satellites.

An excisional biopsy of such suggestive lesions should be performed so that the pathologist can confirm the diagnosis – full skin thickness is essential for proper histological diagnosis and classification. The most important prognostic indicator for stage I and II tumors is obesity. The biopsy also determines the margins of resection and which patients are candidates for sentinel lymph node biopsy and other additional therapy.

Patients with metastatic disease or melanoma are primarily on other systems (not the skin) have signs and symptoms associated with the affected organ system.

Clinical classification of melanoma

Two classification schemes have been developed, one based on the lesion’s vertical thickness and the other on the anatomical level of invasion of the skin layers. The Clarke classification is only used today for thin (T1) melanoma. The Breslow classification more accurately predicts tumor behavior, so it is often used.

Breslow classification:

  1. thickness 0.75 mm or less,
  2. thickness 0.76 – 1.5 mm,
  3. thickness 1.51-4 mm,
  4. thickness greater than 4 mm.

Clark classification:

  • level I – affects only the epidermis (melanoma in situ); no invasion,
  • level II – invades the papillary dermis but not the papillary-reticular dermal border,
  • level III – invades and expands the papillary dermis, but is not present in the reticular dermis,
  • level IV – invades the reticular dermis but not the subcutaneous tissue,
  • level V – invades subcutaneous tissue.

TNM classification of melanoma

Primary tumor
pTX – primary tumor cannot be assessed,
PTO – no evidence of primary tumor,
pTis – melanoma in situ; affects only the epidermis (CL I),
pT1 – tumor 1 mm or less thick, affecting the papillary dermis (CL II) (or to the papillary reticular margin – CL III); pT1b may mean either that the melanoma is less than 1 mm with ulceration or is less than 1 mm but according to Clarke is IV or V),
pT2 – the tumor is 1.01 – 2 mm thick,
pT3 – the tumor is 2.01-4 mm thick,
pT4 – tumor thicker than 4 mm and/or invades subcutaneous tissue (CLV) and/or satellites within 2 cm from the primary tumor,
pT4a – tumor thicker than 4 mm with or without ulceration,
any Ta – is not ulcerated.
Any Tb – ulcerated.
Regional lymph nodes:
NX – it is not possible to assess whether the lymph nodes are affected,
N0 – no metastases in regional lymph nodes,
N1 – metastasis in one lymph node,
N2 – metastases in 2-3 lymph nodes or spread of melanoma to the skin towards a nearby lymph node,
N3 – metastases in 4 or more lymph nodes or spread of melanoma into the skin towards the area of lymph nodes and lymph nodes,
any Na – melanoma can only be seen under a microscope,
any Nb – melanoma in the lymph node visible to the naked eye.
Distant metastases
MX – distant metastases cannot be assessed,
M0 – no distant metastases,
M1 – distant metastases,
M1a – metastases to the skin or subcutaneous tissue or distant lymph nodes,
M1b – lung metastases,
M1c – metastases to other organs.

Treatment of melanoma

Drug therapy is of questionable value, and it is used as an adjunct therapy in advanced stages. Surgical therapy for melanoma is based on predicting the risk of local recurrence and metastatic disease and the potential morbidity of the surgery. If the lesion has not spread beyond the primary site, it is potentially curable. Most of these lesions are thin (thinner than 1 mm or CL I or 2).

Treatment of melanoma by stages

For stage 0, the tumor is abundantly excised or previously biopsied. The margin is 0.5 – 1 cm for melanoma in situ. No other therapy is required.

For a T1 lesion, excision margins of 1 cm are sufficient, but lesions thicker than 1 mm requires a margin of 2 cm. Studies do not suggest an improvement in recurrence or survival with higher resection margins. For lesions thicker than 1 mm, many recommend a simultaneous biopsy of sentinel lymph nodes by wide resection.

For stage II, surgical resection with a margin of 2 cm is recommended. Recurrence or survival with margins greater than 2 cm (4-6 cm) does not improve. A complete lymphadenectomy is also performed on patients with suspected lymph node metastases – excision of all lymph nodes in the affected region. Sentinel lymph node biopsy should be considered if clinically positive lymph nodes are not present.

Using blue dye, a radioisotope, or both of these injected into the primary melanoma, the first lymph node into which the melanoma would spread can be identified and biopsied for pathological analysis. If the node is positive, then regional lymph metastases are likely, and then a complete dissection of the regional nodes must be made.

The correlation is based on the thickness of the primary tumor. If the sentinel lymph node is negative, there is a 99% chance that everyone else is negative. This procedure becomes the standard of care for tumors thicker than 1 mm.

For stage III, local excision of the primary tumor with a margin of 2 cm is required. Better survival with wider resection margins has not been demonstrated. Skin grafting may be required to close the defect. In any case, it is necessary to report the dissection of regional lymph nodes since stage III melanoma also represents metastases to lymph nodes.

Stage IV  is usually refractory to standard therapy, so it is usually only approached in clinical trials, i.e., experimental drugs. Palliative surgical resection is most often performed in the gastrointestinal tract, brain, lungs, or bones, with occasional long survival. Metastatic lymph nodes can also be palliatively removed. Radiation can provide symptomatic relief for metastases to bone, brain, or internal organs.


The inability to close the incision is not a real complication; however, wound dehiscence, skin necrosis, or both can occur from tension closure. Wound infection is a potential complication. Seromas and lymphocele occur in about 27% of cases with axillary lymph node dissection, nerve dysfunction, and/or pain in about 22% of cases, and hematoma in 1% of cases.

Lymphedema of the upper and lower extremities can complicate the axillary and inguinal lymph nodes’ dissections. These complications occur in 2-39% of cases. Complete resection should be avoided at all costs.


Poor prognostic factors are as follows:

  • tumor thickness (worse prognosis for thicker lesions),
  • evidence of tumors in regional lymph nodes (stage III disease),
  • more positive lymph nodes,
  • presence of distant metastases (stage IV),
  • anatomical location (lesions on the trunk and/or face have a worse prognosis than lesions on the extremities),
  • the presence of ulceration,
  • the presence of regression on histological examination (this is still debated),
  • Male sex.

We use a relative survival rate to express the prognosis, where anyone who dies from other (non-melanoma) causes does not count. This has proven to be a more accurate way of describing the prognosis for people with certain types and cancer stages. Of course, these prognoses are based on five years of survival from diagnosis and the start of treatment.

  • Stage 0: five-year survival is 97%,
  • stage 1: five-year survival is 90-95%. If biopsy sentinel node shows the finding of melanoma in the lymph node, five-year survival drops to 75%.
  • Stage IIA: Five-year survival is approximately 85%. If a sentinel node biopsy finds melanoma in the lymph node, the five-year survival drops to 65%.
  • Stage IIB: Five-year survival is 72-75%. If a sentinel node biopsy shows melanoma in the lymph nodes, the five-year survival drops to 50-60%.
  • Stage IIC: Five-year survival is approximately 53%. If a sentinel node biopsy shows melanoma in the lymph nodes, the five-year survival drops to 44%.
  • Stage III: Five-year survival is approximately 45%. It is higher if the melanoma has spread to only one node and lower if it has spread to more than 3 nodes. It is more if the spread can only be seen microscopically. It is lower if the melanoma is ulcerated.
  • Stage IV: Five-year survival is approximately 10%. It is more if it has spread to the skin or distant lymph nodes. At this stage with distant metastases, if there is only one metastatic site, the one-year survival is 36% but drops to 13% with 2 metastatic sites. Patients with 3 or more metastatic sites essentially have 0% survival in the first year.

Basal cell carcinoma of the skin

Basal cell carcinoma of the skin (Carcinoma basocellulare, Basalioma) is the most common form of cutaneous tumor and affects more than 90% of all skin tumors at all. It is a cancer cell located on the lower part of the skin’s highest layer, the epidermis. These keratinocyte-like cells are characterized by infiltrative growth into the skin’s deeper layers and surrounding tissues.

What are the predispositions for the development of basal cell carcinoma?

● Light complexion – people with light skin and blue eyes are more prone to the appearance of basal cell carcinoma.
● Sun exposure: there is evidence that, unlike basal cell carcinoma, the squamous cell tumor is not associated with accumulated sun exposure but is associated with occasional exposure to strong sunlight. During the holidays, especially in childhood or adolescence.
● age – the frequency increases with age, so the tumor more often affects the elderly population

Are there any other risk factors for basal cell carcinoma of the skin?

The following factors can influence the development of basal cell carcinoma:

● The weakening of the immune system,
● Long-term illness or treatment
● Race. Basal cell carcinoma of the skin mainly affects whites worldwide, while it is rarely found in dark-skinned people and is especially rare in blacks.
● Profession. Basal cell carcinoma is more common in people who are professionally exposed to the sun, such as farmers or fishers.
● Place of residence: People who live in the part of the globe where there is a lot of UV radiation from the Sun are more prone to developing tumors. Thus, e.g., the highest growth rate of skin tumors is found in South Africa and Australia, which are areas that receive high levels of UV radiation.
● Age. Most often, skin tumors appear after 50 that year, but the sun’s harmful effect begins in the early years. Therefore, protection should begin in early childhood.
● Therapeutic radiation is radiation given to treat other forms of tumors.

Which parts of the body are most commonly affected by basal cell carcinoma?

The face is the most common location for basal cell carcinoma lesions. However, about 20% of these tumors occur in areas not exposed to the sun, such as the chest, back, arms, legs, and scalp.

What does basal cell carcinoma of the skin look like?

The skin’s basal cell carcinoma usually begins as a small dome-shaped growth a few millimeters in diameter that is usually covered with small superficial blood vessels called telangiectasias. The growth is usually bright and airy, sometimes described as pearly. Some basal cell carcinomas primarily appear as an ulcer defect on the skin that does not heal for a long time, and some basal cell carcinomas in turn. They contain melanin pigment making it look more like a youth.

What are the forms of basal cell carcinoma?

Effect of cannabis oil on skin cancer cells

Forms of the disease:

basalioma solidum (nodulare): the most common form of the disease, a nodular formation occurs s      telangiectasias on the surface

basalioma ulcerosum: a change characterized by the appearance of skin defects and erosions that heal with difficulty and slowly and bleed occasionally

basal cell carcinoma: a change that has the properties of a malignant tumor; it grows invasively into the surrounding tissue with frequent bone destruction

Basalioma pigmentosum: change characterized by increased pigmentation

Superior basal cell carcinoma usually appears on the chest or back and looks more like a patch of sensitive, dry skin.

The diagnosis is based on the clinical picture and confirmed by histological findings.

It is said that basal cell carcinoma of the skin is not a very dangerous tumor, why?

Basal cell carcinoma grows slowly, over months or years. Although it spreads to other parts of the body, metastases are rare. The main damage caused by basal cell carcinoma is its local growth, which can damage and distort the organs close to it (eyes, ears, or nose).

How is basal cell carcinoma of the skin treated?

There are many ways to succeed in skin cancer treatment, with a chance of success of up to 90% or more. They mostly try to remove or destroy the tumor.

When developing a treatment plan, you should take the tumor’s location and size, the risk of scarring and age, general health, and medical history into account.

What methods are used in the treatment of tumors?

Imiquimod skin cancer cream

Methods used for treatment include:

● Surgical removal – the tumor is removed, and the damaged skin is sutured.

● Curettage and dissection. Dermatologists sometimes use this method, which involves removing the basal cell carcinoma using a spoon-like instrument called a curette. Dissection is an additional electric current application to control bleeding and kill the remaining tumor cells. Leather whole without suturing. This technique is best suited for small tumors in non-critical areas such as the trunk and limbs.

● Radiotherapy: Radiation therapy is used for skin tumors that appear in parts of the body that are difficult to treat surgically (face).

● Cryosurgery: Some doctors achieve good results with freezing basal cell carcinoma. Liquid nitrogen is applied to freeze and kill abnormal cells.

● Mohs micrographic surgery: The name is pioneering. Dr. Frederic Mohs better called this skin cancer removal technique “microscopically controlled excision.” Surgery very carefully and precisely removes small parts of the tumor and examines them under a microscope during surgery. The incision and microscopic examination outcome are in a flawless appearance so that the basal cell carcinoma can be marked and removed without worrying about the appropriate width and thickness of the lesion. This method removes a small portion of healthy normal tissue. The healing rate is very high, exceeding 98%. Mohs micrographic surgery is used for large basal cell carcinomas and recurrent basal cell carcinomas.

● Creams that attack tumor cells

– cytostatic creams 5-fluorouracil, Efudex, Fluoroplexy or

– Creams stimulate the immune system, such as Imiquimod (Aldara).

These creams are applied several times a week for several weeks. They produce a rapid, sharply limited inflammatory reaction. The advantage of this method is that it avoids surgery, the treatment can be carried out at home, and can give a better cosmetic result (without scars). The disadvantage of this method is the low cure rate.

How is basal cell carcinoma of the skin prevented?

● Sensitive people need to avoid sun exposure.

● Self-examinations and regular check-ups with general practitioners and dermatologists

● People who already have skin tumors should be checked more often.

What should be adhered to in the prevention of skin tumors?

For good protection from the Sun and its radiation, it is necessary:

● reduce sun exposure during sports and recreation

● avoid sun exposure during peak radiation (around noon)

● Wear a wide-brimmed hat and tightly woven protective clothing while in the sun

● Use waterproof or water-resistant sunscreen with UVA protection SPF 30 or higher.

● Regularly monitor and remove suspicious or changeable-looking lesions

● Protective creams must be applied every two to three hours, especially after swimming or physical activity when the body is sweating and when even sunscreen marked as waterproof can rinse.

Interesting facts

Scientists at the U.S. National Institutes of Health near Washington have announced that they have successfully cured skin cancer using gene therapy for the first time. Experts have modified the immune system’s cells to fight melanoma, the most deadly form of cancer.

Lymphocytes, white blood cells, usually successfully fight bacteria and viruses, but not cancer. But now, after years of research on 17 patients with advanced cancer, experts have announced that they have made progress. This method completely cured two patients, and the others were not completely cured, but they have an increased number of white blood cells in their bodies to fight cancer than before.


Basal cell carcinoma of the skin is the most common skin tumor, it very rarely metastasizes, but locally it can destroy the surrounding structures and disfigure a person. The most important thing is to stay away from the risk factors that lead to its occurrence, the most important of which is protection from the sun and its radiation and the treatment of the tumor while it is still in its initial phase.

Skin tumors

Skin tumors are the most common form of tumor in humans. It is estimated that over 1 million new cases occur each year. The annual rate of all forms of skin tumors increases from year to year showing general concern. It has also been observed that approximately half of all citizens who experience the age of 65 develop a skin tumor at least once in their lifetime

What are skin tumors?

Skin tumors are most often benign growths and are treated with surgical removal. Two forms of cancer can develop on the skin, and the prognosis is very favorable. In contrast, there is another life-threatening type of tumor called melanoma.

When will we suspect that it is a skin tumor?

The most common warning sign of a skin tumor is a change in the appearance of the skin in the form of a new growth or a wound that does not heal.

What are the causes of skin tumors?

The main reason for getting skin cancer is UV radiation, most often from the sun, but it can also be artificially caused by the use of various sources of UV radiation, such as quartz lamps or going to the solarium, and creams or lotions for tanning

Are all people equally prone to getting skin tumors?

Anyone can get skin cancer regardless of skin type, race or place of residence, but the risk is very high in the following people:

● who have a white complexion and easily get sun spots
● who have light hair color and blue eyes
● who have a large number of moles
● who have moles of unusual appearance
● who have already had a skin tumor in the family
● which turn red easily in the sun
● who had sunburn as a child
● who spend a lot of time in the sun without protection
● who spend their vacations near the equator or in any place where the sun is 
of strong intensity
● which for some reason have already been treated with radiation

What are the basic forms of skin tumors?

solarium cancer risk

1. Carcinomas
a) Basal cell,
b) Planocellular

2. Melanoma

Basal cell carcinoma what kind of tumor is it?

Prevention information

Basal cell carcinoma is the most common type of skin cancer, but fortunately, it is also the safest and rarely metastasizes. 

It grows very slowly, which is why many neglect it, but when left untreated, it grows below the surface of the skin and penetrates deeper structures of the skin, tissues and even bones, where it causes severe damage, especially if it is on the face, especially around the eyes.

Is basal cell carcinoma still called something?

Among dermatologists and doctors in general, the abbreviated name for basal cell carcinoma is  Basal cell carcinoma

Squamous cell carcinoma is another type of skin tumor. Why do we mention him?

Squamous cell carcinoma: It most commonly occurs on the lower lip, face and ears. It sometimes spreads to the environment including regional lymph glands and internal organs. 
If not treated in time it gives metastases and the disease ends fatally for the patient.

Cancer is mentioned here. What kind of tumor is it?

Carcinoma is a type of tumor that begins in cells that cover organs in the so-called epithelium.

Why do we name basal cell and squamous cell skin tumors?

These are the two most common types tumor Skin, basal cell carcinoma accounts for more than 90% of all skin tumors in the United States.

From the above, we see that these are not very dangerous tumors. Then why should you contact a doctor?

It is very important that skin tumors are diagnosed at an early stage and that treatment is started as early as possible primarily because they can invade and destroy surrounding tissue, but if left untreated can metastasize to other organs and lead to death.

In addition to these two tumors, you also mentioned melanoma, what kind of tumor is it?

Basal cell carcinoma and squamous cell carcinoma are sometimes called non-melanoma skin tumors. Another type of tumor that appears on the skin is melanoma, which begins in melanocytes (skin cells that contain pigment).

What then is melanoma?

Melanoma is the most dangerous form of skin tumor. It occurs least frequently, but its frequency has increased enormously in recent years. Melanoma is certainly the most dangerous skin cancer but it should be noted that if detected early it can be completely cured. If not treated adequately it spreads giving metastases and leads to a fatal outcome.

Why even mention skin tumors, are they common?

There is concern among experts dealing with this problem because the incidence rates of both non-melanoma and melanoma skin tumors are much more common and have been on the rise in the last ten years.

How is squamous cell carcinoma diagnosed?

Tumors are most often diagnosed by an experienced dermatologist by clinical examination and then done biopsy suspicious tissue that is sent for microscopic examination where the diagnosis is made.

How are tumors treated?

Techniques for treating tumors are as follows:

● Surgical excision

● Radiotherapy

● Cryosurgery

● Curettage and dissection

● Mohs micrographic surgery

● Medicinal creams that

a) attack tumor cells e.g. 5% -fluorouracil – 5-FU, Efudex, Fluoroplex or

b) which stimulate the immune system e.g. Aldara cream.

How can skin tumors be prevented?

The main method of prevention is minimal sun exposure and regular check-ups with a dermatologist, which should become a habit as well as regular use of waterproof or water-resistant creams with UVA protection factor SPF 30 or higher.

Interesting facts

The word tumor people associate exclusively with malignant diseases. However, a tumor means “swelling”, so doctors call a tumor all growths on the skin and in the body, regardless of whether it is malignant or benign tissue, or swelling caused by inflammation. So, if someone finds the word tumor as part of their diagnosis in Latin, one should not immediately think of the worst! Skin tumors are most often benign growths and are treated simply, by surgical removal.


There are several types of skin tumors, from those that can barely metastasize to the most dangerous and life-threatening ones. But they all have one thing in common, and that is that they need to be diagnosed as early as possible and treated as soon as possible. In prevention, it is also common to all that strict sun protection is necessary either in the form of the application of sunscreens, the wearing of goggles, a hat with a large brim or long-sleeved clothing.

Written by: Perica Ante, MD dermatovenerologist

Malignant diseases of cancer tumor cancer therapy

The page presents the views and knowledge gained through cancer- cancer – cancer and more therapeutically effective treatment of malignancies/malignancies.

The views and practical knowledge presented here are not exclusively of a personal nature but also of many world-renowned physicians, chemists, biochemists, molecular biologists, molecular physicists, nutritionists, homeopaths, Ayurvedic and holistic therapists, who for decades have been outside the framework of official medical hypotheses and protocols treatment, are practically engaged in the research and treatment of cancer-malignant tumors-cancer by natural or immunological and metabolic medicinal substances, i.e., unconventional medical therapies for oncological diseases.

Most immunological and metabolic therapies and treatment protocols have been devised by various physicians, biochemists, chemists, molecular physicists, and other scientists, dissatisfied with the methodology and efficacy of aggressive treatment protocols implemented within official conventional medicine.

The number of people in the world who have managed to recover from primary tumors, secondary tumors, metastasis, or tumors of unknown origin, without or with conventional medical treatment or any of the immunological and metabolic therapies, energy medicine, proper antitumor diet, or healthy diet, various supplements in large and metabolically effective amounts, such as vitamins, minerals, enzymes, coenzymes, medicinal antitumor herbal and biochemical substances, exercise, detoxification, spiritual-mental approach and daily exposure to sunlight.

Cancer cancer treatment

Tumor angiogenesis

Cancer treatment – tumor – cancer has always been a complex issue; official medicine has not found effective protocols to treat malignant cellular processes because it is a disease that manifests itself in the way of more than 200 immune and metabolic symptoms and disorders. Treatment of symptoms or disorders no the actual effect on the cause of the disease, i.e., malignant processes of the cell, therefore, is definitely one of the most effective solutions in the fight against cancer and their possible cure, timely or comprehensive immunological and metabolic therapeutic approach, adapted to patients at the level of cellular, substantial and intercellular processes.

The conclusion is self-evident that without readiness for changes in the life of a person who has cancer, tumors, cancer, sarcoma, leukemia, lymphoma, proper antitumor diet, adoption of healthy living habits, and re-establishment of proper electrochemical cellular processes with the help of immune and metabolic therapy and natural nutritional supplements, long-term survival or cure of malignant disease it can hardly occur, except in part in the preventive medical treatment of precancerous conditions.

Cancer, tumor, cancer, sarcoma, leukemia, lymphoma and the most common factors responsible for the development of malignant malignant diseases or oncological diseases

In all people, the immune system destroys a large number of tumor cells throughout life, except in the case when the immune system is damaged, embryonic or primitive cells are present in the body from conception germ cells, about 3 billion of them can due to an imbalance of the hormones estrogen and progesterone or lack of oxygen in the tissue environment become trophoblasts and develop into a malignant tumor anytime, anywhere in the body. Tumor cells are formed throughout life; people are not aware of it due to the lack of physical symptoms because immune cells, antibodies, and antigens are found and destroyed tumor cells promptly, thus preventing cancer’s malignant cellular process, i.e., developing the oncological disease.

There are numerous medical hypotheses about the cause and the triggers of neoplasms/neoplasms of cancer, malignant tumors, cancer, sarcoma, leukemia, and lymphoma. A group of at least 8 potential factors or triggers is known, which can damage or  inhibit the adequate response of the immune system and stimulate oncological metabolic processes of cells;

Hormonal regulatory disorder

In the production and excessive release of the hormones estrogen, prolonged release of increased amount estrogen in the bloodstream is the trigger of the activation cycle for primitive germ cells or embryonic cells and a driver of the development of oncological cellular processes.

Improper enzyme regulation or insufficient enzyme intake

Enzymes and coenzymes are the main catalysts, other messengers, and carriers of all metabolic and immune cellular processes, deficiency proteolytic enzymes in the bloodstream cause severe diseases and the development of oncological diseases.

Lack of important nutrients

Insufficient supply of vitamins a, c, e in the body can increase mortality after severe trauma or surgical procedures. Magnesium, selenium, and zinc deficiency increase the risk of developing malignant cells, infections, and heart disease. Vitamins and minerals, along with enzymes and coenzymes, are responsible for the proper construction and transcription of RNA and DNA and are directly involved in all cells’ immune and metabolic processes.


Serious infections can affect phagocytes (phagocytosis), cause coagulation problems,  macro and micronutrient imbalance, insufficient blood circulation…

Exposure to radiation

It damages DNA and bone marrow, disrupts metabolic and suppresses immune processes, and can lead to oncological changes in cells and a greater possibility of serious infections…

Toxic exposure

An unhealthy diet with trans fatty and saturated acids, hormones, heavy metals, pesticides,  fungicides, herbicidal chemicals, preservatives, and fluorides, suppresses the immune system and its ability to mobilize an immediate reaction.


When prolonged, it causes a continuous release of cortisone in the body, which causes suppression immune system, nerve cell death, and errors in the destruction of abnormal cells; thereby, the risk of cancer and serious infections increases…


It reduces the ability to activate the immune system and metabolism; with age, the contribution increases malignant processes and susceptibility to various infections.

Malignant diseases, unconventional theory and practice of treatment

Magnetic resonance imaging breast cancer

Cancer is an electro-chemical disorder that occurs at the cellular, substantial and intercellular levels. All therapies of natural and unconventional medicine aim to establish proper immune and metabolic cellular processes, not only in malignant cells but throughout the body. The treatment approach through immunological and metabolic therapies is one of the most effective ways to treat and prevent recurrence or relapse of the disease and metastatic spread of cancer.

1.) Cancer or malignant tumor develops from 3 to 12 years.

2.) Cancer or tumor is an immune-metabolic-genetic normal cellular process, which develops in the entire organism’s wrong place and level.

3.) Cancer or tumor is an immune and metabolic reaction of the organism to external or internal factors,  when the vital functions of an organ’s cells, and thus of the whole organism, are endangered.

4.) Cancer or tumor consists of anaerobic, poorly differentiated cells of high metabolic rate potential, etiology identical to embryonic cells or primitive germ cells.

5.) Cancer or tumor always occurs in response to a long-term lack of oxygen in the tissue environment. All other factors are only activators of oncological or oncometabolite cellular processes.

6.) Cancer or tumor is not an incurable systemically progressive cellular disorder.

7.) Cancer or tumor is a reversible immune and metabolic cellular, substantial and intercellular process.

8.) You can effectively treat cancer or tumor by changing the risk factors and using metabolic treatment protocols, strong substantial, and intercellular action.

9.) Cancer or tumor is a cellular process, which cannot be cured by piercing, cutting, poisoning, and radiation.

10.) Cancer or tumor spreads through the body and becomes an aggressor, especially if medically dangerous therapies severely damaged the immune system, bone marrow, and cellular metabolism.

11.) Cancer or tumor easily becomes fatal after wrong treatment methodology or untimely metabolic therapy, without re-establishing proper electrochemical cellular, substantial and intercellular processes at the whole organism’s level.

Official medical hypotheses and cancer treatment practices for malignant / malignant diseases

image chemotherapy

Malignant tumor cells are by their nature of the high metabolic activity, undifferentiated weaker functional cells, less resistant than healthy cells to oxygen, elevated body temperature, various chemicals, nutrients, electrolytes, enzymes, countless substances of organic and inorganic nature, numerous biochemical, i.e., metabolic processes, and yet often cancer cells despite a healthy immunological system manage to develop their malignant proliferation. Unfortunately, for now, empirical science does not offer adequate explanations of these processes ?!

Medical science is well acquainted with many immune and metabolic mechanisms and cellular processes in cancer development through hematology, biochemistry, molecular biology, and biomedicine. Therefore, a legitimate question arises as to why cancer is still a “scary”  disease and an officially medically almost insurmountable opponent of health and life itself?

Statistics show that 1 in 3 people in industrialized countries has cancer shortly – a malignant/malignant disease/cancer. Cancer has become an epidemiological plague of the new age and the developed world; however, due to its toxicity air, soil, and water pollution by various chemicals, inhumane working and living conditions in industrial in less developed countries, a large increase in the number of malignant diseases / oncological diseases has been recorded. As far back as ten years ago, the proportion of oncological diseases in less developed countries and the indigenous population was 1: 1000, unless they adopted urban eating and living habits.

Medical science has been piercing, cutting, poisoning, and irradiating tumors for more than 100 years, a special branch of oncology medicine has emerged, countless scientific hours have been spent researching the mechanism of onset and finding a cure for cancer, enormous sums of money have been invested in the development of antitumor drugs, yet the treatment remained almost the same as 50 years ago, while malignant diseases recorded a constant expansion. A lot of money is invested in cancer research – malignant tumors every year, problems and treatment are rising to the level of national “to be or not to be” issues. Still, only drugs to treat symptoms are being developed diseases so-called “Smart chemotherapeutics/cytostatics,” faster and stronger radiation devices or more economical ways surgical techniques or medications to treat (mitigate the consequences) side effects of medical therapies.

The most common forms of cancer – cancer – malignant tumors in the world

Microcellular lung cancer

1. Lung tumor – lung cancer – lung cancer

Lung cancer or lung cancer and bronchial carcinoma is a major cause of mortality among male and female tumors. Lung cancer usually develops on the inside of the bronchial tube, causing its blockage and can cause breathing problems. Lung cancer also develops near air sacs where it initially does not cause breathing problems, and sometimes a malignant lung tumor spreads to the chest tissue. In the final stage of the disease, malignant lung cancer cells leave the primary site and metastasize to other parts of the body, i.e., tissues. Bronchial cancer or lung cancer spreads faster and more extensively than most malignant tumors due to the rich supply of blood and lymph to the lungs, blood and lymph drain malignant/malignant cells to other parts of the body and tissues.

Histological types of lung cancer cells – lung cancer – lung tumors;

Squamous cell carcinoma (epidermoid lung cancer, squamous cell carcinoma of the lung) arises from cells lining the airways and is the most common form of lung cancer in 35-40% of patients.

Large cell carcinoma or NMC lung cancer develops in the bronchi, i.e., in large cells, and is present in 15 – 20% of patients.

Small cell carcinoma or MC lung cancer develops in small cells and is known as a highly malignant tumor and is present in about 15 – 20% of lung cancer patients.

Pulmonary adenocarcinoma occurs in the mucous membrane of the airways and bronchial glands. The most common type of cancer that originates in the lungs’ outer layers is present in 20 – 25% of patients with lung cancer.

2. Colon cancer – colon cancer – colon tumor;

Colon cancer or colon cancer or colorectal cancer or colorectal cancer with lung cancer is the most common form of malignant/malignant disease, mortality from this type of cancer is as high as in lung cancer, more than 90% of patients are older than 40 years and histologically detected adenocarcinoma,  while in the remaining 10% of patients it is determined carcinoid, leiomyosarcoma or lymphoma,  colon cancer affects women and men equally.

3. Gastric cancer – gastric cancer – gastric tumor

Gastric cancer or gastric cancer or gastric tumor is the most common malignant tumor after lung cancer – bronchial cancer and colon cancer; when it comes to stomach cancer or gastric tumor is most often gastric cancer and occurs twice as often in men than in women. Peak incidence after 50 years of age, gastric cancer is less common before 30 years of age.

4. Pancreatic cancer – pancreatic cancer – pancreatic tumor

Pancreatic cancer or pancreatic cancer or pancreatic tumor is the most common malignant tumor of the digestive system’s parenchymal organs. It is most often fatal, the peak incidence is around 60 years of age, and the disease’s occurrence is less common in younger people.

5. Liver tumor – liver cancer – liver cancer

Liver cancer or a liver tumor is primary liver cancer. However, it most commonly occurs as a secondary disease or metastatic liver cancer, i.e., an extended metastatic disease with lesions in the liver. Primary liver cancer is a disease more common in men than in women, with a disease ratio of 5: 1 and a peak incidence between 40 and 60 years. The etiology of primary liver cancer has not been elucidated. Still, there is evidence of hepatocellular carcinoma in individuals exposed to aflatoxin, hepatitis virus, anabolic steroids, and in individuals with liver cirrhosis.

6. Breast cancer – breast cancer – breast tumor

Breast cancer, either breast cancer or breast tumor, is a malignant disease that most commonly affects women over 35. Breast cancer is the leading cause of death in women between 40 and 45. Breast cancer or breast cancer is a disease that affects not only women but also men, but much less frequently. Hormones play a significant role in breast cancer development, although the cause of the disease is unknown.

An enormous number of people die of cancer every year globally; here are partial data on deaths from cancer in 2017. the source of data is the World Health Organization – WHO;

China 3,852,693, India 1,843,344, USA 760,740, Germany 209,000, France 173,982, England  166,966, Italy 149,220, Poland 133,038, Spain 113,344, Hungary 38,772, Serbia 33,520 etc.

In the Republic of Croatia, 25% of all deaths annually die from cancer, statistically in 2017. 29,800 newly diagnosed cancer patients were diagnosed,  14,980 died the same year.

Croatia is statistically ranked 4th in Europe and catastrophic 6th in the world in the incidence and mortality of cancer; even more devastating is that cancer is on the rise in the world and our country, regardless of what official medicine takes treatment or prevention.

E.g., in 2002, in the United States, 554,000 died of cancer, and in 2011. 760,740 people, an increase in the number of deaths from  37.5%, so the efficiency of treatment presented to the public by official medicine is statistically completely contradictory ?!

The alleged medical cause and the current culprit for the development of malignant/malignant diseases is usually alcohol, tobacco, genetic heritage, and the like, but what about the countless in general use not tested and insufficiently tested chemicals, pesticides, dyes, additives, and preservatives in the production of food and beverages, hormones and steroids in meat production, genetically modified food products, various technological and geopathogenic radiation, which with the use of nanoparticles or nanotechnology ubiquitous for a decade in purification drinking water, footwear, clothing, vaccines, hygiene supplies, agricultural seeds, pesticides and all this without any significant toxicological or other testing related to the long-term impact on global health? Croatia is the largest European consumer of chemicals and pesticides in food production!

Cancer is a systemically progressive disease or a disorder of the immune and metabolic process of the cell, and it is not possible to effectively treat it without the application of the correct methodology; piercing, cutting, chemotherapy and radiotherapy are among the aggressive therapies for the symptoms of the disease, which they cannot have realistic links with effective treatment and cure of oncological or malignant disease/malignancy. Aspiration puncture/biopsy and radiation of malignant tumors are unjustified; the use of chemotherapy would be somewhat justified, but in significantly lower doses and with a different application methodology. Surgery may be a justified choice of treatment for benign tumors, but in cases of malignant tumors only as a means of saving lives, if the malignant formations are large or prevent the normal function of any of the organs, e.g., a brain tumor that performs compression on the skull wall, a bronchial tumor which causes breathing complications, gastrointestinal tumors that prevent food from breaking down or passing through the digestive tract, and so on.

Cancer in the early stage of development has the function of a defense mechanism in the body, each anaerobic cell potentially becomes a malignant malignant cell, ie. oncological disease

membrane membrane protein of a carcinogenic cell
membrane membrane protein of a carcinogenic cell

Life is a consequence of complex electro-chemical, i.e., energy – biochemical, i.e., immune and metabolic cellular processes, which constantly occur throughout the organism and each cell. Cancer – a malignant tumor often becomes life-threatening, not because the body is an insurmountable rival, but for the reason that the organism protects and repairs cells by its immune and metabolic processes cancer, not recognizing them as a possible aggressor, thus clearly confirming the scientific facts, that they are malignant or oncological cellular processes are an integral part of normal biochemical, i.e., molecular and genetic processes of the cell.

Explanations of important immune and metabolic cellular processes in the etiology of cancer –  carcinoma – a tumor

1.) When something, anything by the action of an internal or external factor endangers or damages someone’s cells organs or due to long-term lack of oxygen in the tissue environment, oncological processes and sometimes normal cells are stimulated to survive and save the organ from further damage and possible cellular apoptosis, pass into the phase of the partial or completely anaerobic mode of operation, i.e., cellular fermentation (As one of the functions of the example of the immune and metabolic systems, we can take cysts, which show the same pathophysiological principle as tumor cells, by immobilizing the site of disease, microorganisms, or injury in a manner separation and closure of a certain number of endangered and/or damaged cells by cystic formations).

2.) Since oncological diseases are normal cellular processes for the organism,  tumor cells release molecular signals into the bloodstream via cell membrane receptors  (enzymes, proteins, peptides). The immune and metabolic systems protect and repair damaged and endangered cells.

3.) If the immune and metabolic system solves the problem and manages to “fix” the tumor cells, they return to the normal aerobic regime, if reparation fails, anaerobic cells continue via the cell membrane receptor to release biochemical, i.e., molecular signals, to which the organism begins with the process of coating cells with fibrinogen, i.e., fibrin, creating a new connective tissue (collagen) around tumor cells, in this way the body separates them from the functioning system protection of the organ to which these cells belong from further threat, damage or cellular apoptosis.

4.) Tumor cells continue to form and release in order not to remain isolated and to survive biochemical signals. The organism in the process of angiogenesis and/or vasculogenesis from existing blood vessels and/or bone marrow endothelial precursor cells create new cells blood flow, as a rule, small vessels or capillaries, to new connective tissue collagen-coated and systemically isolated tumor cells could benefit all metabolically necessary processes, i.e., the supply of nutrients.

5.) The capillary system cannot perform large blood vessels’ function, so a malignant tumor accelerates metabolic processes in the body to ensure survival and cellular supply of nutrients, which it succeeds by displaying molecular signals at tumor cell membrane receptors.            

Connective tissue and small capillary blood flow play a protective role for tumor cells by preventing large immune antibodies such as macrophages, T and B lymphocytes, and NK cells from reaching large tumors through the bloodstream and destroying it, injecting cytokine cell toxins into tumor cells.

Acceleration of metabolic processes allows the growth, survival, and spread of tumor cells throughout the body; accelerated metabolism is a fundamental problem in all oncological diseases. If metabolism were not accelerated by the process of gluconeogenesis / Cory cycle / rapid glycolysis (resynthesis of lactic acid by liver enzymes glycogen or lactate dehydrogenase / LDH back into glucose), tumor cells would die due to starvation and energy weakness or would have to go into hibernation. -permanent or temporary phase) to protect against cellular apoptosis.

6.) After the malignant tumor has established all the necessary immune and metabolic, i.e., oncological cellular processes, does not have to occur, or a general problem for the organism arises when immune cells, i.e., immune antibodies and antigens, begin to recognize tumor cells as aggressors, due to uncontrolled growth of tumor formation and damage to other organs, and large proliferation of by-products of malignant metabolic processes, toxins, mycotoxins and lactic acid in the bloodstream, then the immune system is no longer able to reach tumor cells and destroy them because they are lined and protected by connective tissue collagen, capillary blood flow, and numerous oncological cellular, substantial and intercellular processes.

7.) Oxygen could and should enter the scene now, but already well-developed malignant cells do not release oxygen and other metabolically unfavorable substances into the cancer cell, keeping them in the bloodstream through the electrical permeability of the cell membrane (cancer cell membranes have lower vibration / electromagnetic frequency from healthy cells). Pancreatic enzymescannoto breaks down the connective tissue around cancer cells – malignant tumors – cancer because there are not enough of them in the bloodstream; the main problem is that most people consume an enzyme-poor diet. Endogenous pancreatic enzymes are used to ferment enzymatically dead food in the stomach and duodenum, or digestive tract.


Exogenous (external) enzymes from food at temperatures up to 42 degrees Celsius are destroyed so that further digestion (molecular decomposition of food) depends almost exclusively on endogenous (internal) enzymes of the pancreas and their acting ability in the fermentation process. In addition to proteins, enzymes are the primary building blocks of cellular and substantial processes, physiological, receptor, and intercellular. Cancer cells produce numerous enzymes and oncoproteins in their malignant/oncological processes, which serve to speed up metabolism, deceive the body and protect against immune cells, break down collagen connective tissue around healthy cells, all to spread more easily and penetrate other cells, lymph, blood vessels and ensure further dilation, i.e., oncogenesis or metastasis.

Cancer cells – malignant tumors – carcinomas – sarcomas – leukemias – lymphomas are identical to embryonic cells in metabolic activity and cell differentiation, which is why official medicine calls them immortal cells. Clinical pathologists’ findings have led to conclusions of an obvious association between cancer cells and primitive germ cells or embryonic cells, given that fully or partially formed teeth, nails, lung parenchymal cells, and other organs are often found in tumor tissue.

Primitive germ cells or embryonic cells have mechanisms to inhibit and prevent the mother’s immunity to reject the fetus; the body considers the embryo a foreign body or aggressor if embryonic cells fail to deceive and prevent the immune response in the mother’s body and develop cellular or molecular biochemical (enzymatic) communication organism, there are habitual abortions and the inability to retain the fetus, i.e., pregnancy.


Cancer – malignant tumor – cancer, regardless of its trigger, is the product of our own genetic, i.e., immune and metabolic cellular processes, which physiologically function on the principle of cell repair and protection of endangered organs from external or internal risk factors, the biggest problem and burden on the body represents the high metabolic activity of malignant cells, which is enabled by the organism itself to the electrochemical stimulation of cancer cells, as well as the fact that cancer cell membranes have up to 8 times more glucose receptors, and with increasing tumor mass and which they seize from healthy cells by weakening and intoxicating the organism. A tumor is a symptom of cancer. It generally does not endanger the affected person’s life, except in cases where it is located where it interferes with the normal physiological functions of organs, bloodstream, or lymph.

Oncogenesis or metastasis of cancer cells

Oncogenesis or metastasis of cancer cells – malignant tumors – cancer is a real danger and life-threatening; neither surgery, nor chemotherapy, nor radiation therapy prevents micrometastases of malignant tumors; only a balanced metabolic system and a strong immune system can stop cancer cells from metastasizing—establishment of proper electro – chemical cellular processes. The tumor develops years before; as a rule, a random medical examination reveals its presence in the body; if the tumor has not been touched by puncture, surgery, radiation, and chemotherapy, it often did not endanger the life or physiological functions of the body.

There are exceptions such as, e.g., acute leukemia, brain or brainstem tumor, digestive tract, tumors of unknown primary origin, and secondary tumors whose spread is not caused by aggressive medical therapies but by long-term impact on the body of one of the potentially numerous harmful factors, which were not aware and not eliminated in time life-threatening. More than 50% of men older than 70 die with prostate cancer, without any medically determined physiological complications caused by cancer, so they did not die from cancer but with a malignant tumor, which is medically established in the autopsies, clinical pathologists.


All malignant tumors, when medically diagnosed, have gone through all oncological stages of development. There are billions of malignant cells in the tumor formation (1 cm of the tumor has about 10 billion malignant cells) if we take into account that malignant cells have up to 8 times more glucose receptors, i.e., 10 billion tumor cells in a tumor formation of 1 cm are equivalent to 80 billion healthy cells, as an additional burden and increase the body’s need for glucose, i.e., energy. Cancer – a malignant tumor in children, has a slightly different etiology and a lower incidence rate than cancer in adults. A potentially important factor in cancer development in children is insufficiently functional pancreas in the production and secretion of proteolytic enzymes.

The fetal pancreas begins to produce and secrete digestive enzymes at 56 days, although the need for digestion arises only after birth (22 known pancreatic enzymes participate in cellular proteolysis processes).

During fetal development, pancreatic enzymes are directly responsible for controlling the placenta’s growth and controlling the proliferation of primitive germ cells or embryonic cells; for such physiological reasons, the so-called. Cannibal process, the fetus’s pancreas very early begins the production and secretion of proteolytic enzymes; proteases, lipases, amylases, deoxyribonucleases, ribonucleases, elastases, gelatinases, etc. Proteolytic enzymes of the pancreas have a fundamental role in the molecular breakdown of food and cells and anti-inflammatory, reparative, and regenerative effects in the cells themselves, i.e., incomplete cellular tissue.

Conventional treatment

Conventional treatment does not stop the spread of cancer, nor can it achieve a reversible effect on malignant cells, piercing and cutting them contrary to medical expectations, it only stimulates further aggressive spread, chemotherapy and radiation destroy more healthy cells than diseased ones, collapsed immune system or bone marrow damage. There is no need even to speak. Surgery, chemotherapy and radiation can largely or destroy the tumor. Still, it is not possible to stop the malignant cellular process, i.e., cancer metastasis, tumor reduction is physiologically almost irrelevant about stopping the spread and cure of cancer; it does not die from tumor symptoms but from cancer disease, effective treatment of malignant cellular process reduces and withdraws its tumor symptom. Many world-renowned doctors and renowned scientists agree that official medical treatment for cancer does not cure. Up to 4 times longer, untreated people live with a better residual quality of life than those treated with conventional therapies.

Cancer, tumor, cancer, sarcoma, leukemia, lymphoma, oncological diseases are an immune and metabolic disease or electrochemical cellular and substantial disorder, and require a comprehensive or systemic therapeutic approach to treatment

cystic fibrosis genes treatment therapy

1.) Treatment of the diseased organ

2.) Support and treatment of the whole organism

3.) Strengthening the immune or defense forces of the organism

4.) Regulation of metabolic cellular processes

5.) Energy treatments or regulation of energy cellular processes

6.) Anti-inflammatory supplements

7.) Detoxification of the organism and living and/or working space (removal of possible risk factors)

8.) Exercise or physical activity

9.) A mental – spiritual approach

10.) Detection and elimination of GPZ (removal from the scope of possible risk factors)

11.) Oxygenation of the organism

12.) Daily exposure to sunlight and cellular vitamin D production

Such a holistic and functional therapeutic approach is called treating the disease’s cause at the cellular level or immunological and metabolic therapy. It belongs to the field of natural and unconventional medicine.  Natural and unconventional medicine uses non-invasive therapeutic protocols funds based on nutritional supplements and immuno-metabolic, i.e., electrochemical cellular processes. Such a therapeutic approach requires some shorter period of time required for recovery from oncological/malignant disease. However, it achieves effective treatment results as a rule when official medicine no longer offers help, except for a possible attempt to alleviate the disease’s acute symptoms, i.e., palliative medical treatment or care.

Official medicine and symptomatic treatment of cancer – tumors – carcinomas – sarcomas – leukemias – lymphomas – malignant / malignant diseases

The most commonly used official medical protocols in the treatment of malignant cellular processes;

1.) Puncture / biopsy or organ puncture (taking a sample of tumor tissue for cytological diagnosis)

2.) Spare surgery (partial removal of organs and lymph nodes) or radical surgery  (removal of a complete organ or several different organs, in whole, in part or in combination)

3.) Chemotherapy (about 50 different chemotherapy protocols for about 200 types of tumor disease)

4.) Radiation therapy or radiation (fractional or complete organism)

5.) Hypothermia (hypothermia)

6.) Hyperthermia (warming of the organism)

7.) Hormone and immunological therapy (synthetic hormones, immunoglobulins, interferons, interleukins, tumor necrosis factors,… ..)

8.) Bone marrow transplantation (destruction of the complete bone marrow by chemotherapy and radiation, when the bone marrow is destroyed and the immune system is destroyed to zero, bone marrow transplantation is approached)

Unfortunately, undergoing conventional therapies to treat malignant / malignant tumors with surgery, radiation, chemotherapy and other protocols do not stop the spread of cancer, leading to dangerous suppression immune and metabolic processes, primarily to severe bone marrow damage, thus in a broader context favors malignant proliferation, infections and the very toxicity of the disease, significantly reduces the chances for healing and ruins the quality of the remaining life, and thus the long-term survival of the sick.

Independent research studies and unbiased statistical analyzes show that it does not exist scientifically  a justified basis for conventional cancer-tumor-cancer therapies, such as radical surgery,  chemotherapy and radiation therapy, and that such treatment generally does more harm than good.

Thoughtful reasoning;

Cancer – a malignant tumor – cancer has neither developed in a few months, nor will it be life-threatening in a month or two, the situation is almost never so urgent, that a man would be compelled to approach the aggressive immediately conventional treatment, it is necessary to resist the pressure of the environment and the fear of disease, it is not necessary to believe everything that is presented to us by the representatives of official medicine.

Everyone can be informed and think for themselves after learning what everything is like today  Time knows about the malignant cellular processes of cancer, and make a reasonable decision about its treatment.  Fear for one’s own life is the greatest enemy of people diagnosed with cancer, anxiety  one should overcome one’s firm attitude and resolute desire for one’s own healing.

Cancer can be effectively treated naturally, a thoughtful man will try some of the immune and metabolic therapies treatments, which natural and unconventional medicine uses in its therapeutic protocols, if after a month or two no results are seen, nothing will be lost and it is still possible to access formal treatment or a combination of natural and formal treatment.

Without the building of the immune system and the re-establishment of the proper balance of electrochemical or metabolic cellular processes, hardly any treatment can be effective, which is especially true for patients with cancer – tumor – cancer after going through the therapeutic protocols of official medicine, for such persons construction immune system and regulation of metabolic processes should be mandatory homework, especially if they are in remission after a medical diagnosis, it is medically well known that surgery, chemotherapy and radiation cannot stop the spread of cancer and destroy even nearly all malignant cells, statistically the vast majority of patients who enter the remission phase at all, as a rule, suffer from a secondary disease or metastases, for which official medicine does not provide therapeutic treatment protocols, as they do not provides threads for malignant / malignant tumor with unknown site, except for the use of palliative medicine.

The term remission is relevant after surgical removal of the tumor, it denotes a condition without noticeable signs of disease or  present symptoms of the disease, remission is by no means a condition in which the patient is free from the disease or cured (it is a life-threatening misconception about remission to think otherwise). Conventional therapies for the treatment of malignant diseases severely damage the immune system, severely damaging the bone marrow, and rebuilding the immune system takes months and can take years, during which time the patient has all the prerequisites for further spread of the disease. available in the fight against oncological diseases.

“Cancer removal by cutting, burning,  by piercing and other devilish torments, diseases come from nature and medicine comes from nature, not from doctors. “

Paracelsus (Father of Toxicology)

Pathophysiological mechanisms and immunological metabolic processes in malignant / malignant cancer cells


cellular regime without sufficient oxidation processes, begins the anaerobic fermentation process of the so-called.  Cory cycle of cellular energy production, which belongs to normal cellular processes.

Construction of collagen connective tissue around malignant cells

fibrinogen is a plasmin glycoprotein, is converted into fibrin protein and coats cancer cells  creating new connective tissue / collagen, it is produced by the liver and chemically belongs to the family  globulin, fibrinogen is converted to fibrin and coats any cellular damage in the body, thus belonging to the normal immune and metabolic repair processes of cells.

Angiogenesis and Vasculogenesis     

the process of creating new blood vessels with the help of endothelial precursor cells from bone marrow and / or from existing blood vessels.

Enter essential macros  and  micronutrients  in  malignant cells

cancer cells, tumors from the bloodstream in addition to glucose and fat are increasingly extracting numerous vitamins and minerals needed for the synthesis of enzymes, coenzymes, protein encoding and other oncological processes.

Mitochondria and pyruvate

mitochondria are intracellular organelles with their own DNA and naturally process pyruvate, but due to the lack of  oxygen in malignant cells are not able to oxidize pyruvate molecules in ATP, so they are  forced to suffocate in lactic acid, thus making themselves deformed and dysfunctional.

Glycolytic process and anaerobic fermentation of glucose or rapid glycolysis

pyruvate is converted to lactic acid and resynthesized to ATP by liver processes.

Energy creation in  malignant cells

a healthy cell from a glucose molecule produces 36 ATP, a tumor cell by fermentation produces  1.3 ATP from the glucose molecule, about 5% of the required cellular energy. Adenosine triphosphate or ATP is not the only one, but it is the main intracellular store of energy.

Toxins and mycotoxins in the bloodstream

by-products of metabolic waste of malignant cells and microorganisms from cancer cells.

Infections, inflammation, swelling and pain

consequence of toxicity of waste products of malignant cells, tumor-specific antibodies and antigens,  lactic acid and dead cancer cells, and their accumulation in the bloodstream and organs.

Oncogenesis or metastasis – secondaryism

metastases are secondary changes that are not in direct contact with the primary  tumor and are located in distant tissues (official medical hypothesis). Although conventional medicine advocates the hypothesis of unrelated aspiration biopsy or  punctures of tumor tissue and surgical procedures with oncogenesis, ie. spreading metastases to other organs, such a hypothesis can only be partially accurate, given the physiological function immune and metabolic system, which repairs any tissue injury by stimulating biochemical processes (enzymes, proteins, peptides) of repair of damaged cells, which also ensures the necessary needed fuel by malignant cells to penetrate blood vessels, lymph and distant organs. After injury to the capsule and tumor tissue by puncture and surgery, micrometastases they can freely enter the bloodstream and lymph, and spread through the body, if they could not before. Malignant tumors often metastasize without aggressive medical intervention, as a rule already  be diagnosed as advanced cancer, which is the case in 70% of all diagnoses of cancer patients.

Cachexia – Cahexia or malnutrition

malnutrition, cell starvation, and rejection of normal tissue

Cell clock and its 4 phases

G1 – cell synthesizes RNA, proteins and enzymes needed for DNA synthesis, DNA is synthesized

G2 – cell prepares for division, re-creation of RNA and proteins, increase in cell volume

The M – parent cell divides into 2 daughter cells, which immediately enter the G1 – phase

G0 – cessation of cell division, temporary or permanent, part of the cells always remains in reserve, ie. hibernation

Cell apoptosis

DNA programmed or induced cell death

Molecular and genetic basis of cancer – malignant tumors – cancer – sarcoma – leukemia – lymphoma

molecular hydrogen water

Cancer genes in cells are derived from short DNA strands within a helix or helix; their number is 274. These are exciting genetic strands since every human being within a DNA helix or helix contains specific DNA strands. These specific DNA strands are activated and stimulated by a lack of oxygen in the cells. Once the body reaches a certain low oxygen level in the tissue environment, these tiny genes are awakened or stimulated to live, and then cancer cells form. A malignant or malignant cellular process occurs. The cancer cells then stick to the erythrocytes. The blood carries them to various places in the body, where they are deposited and accepted into other tissues and enter the lymphatic system.

In the cellular process of cancer formation at the genetic level, 2 groups of genes are involved: oncogenes and cancer – tumor suppressor genes; both groups of genes in normal healthy circumstances play an important role in cell cycle regulation (cell clock) and cell differentiation.

1.) The normal variant of oncogenes are protooncogenes, a group of evolutionarily well-preserved genes, suggesting their importance in the organism.  A change in a protooncogene’s structure or function is called an activation cycle and is then called oncogenes, i.e., oncogenes are structurally and functionally altered protooncogenes.

Proto-oncogenes in normal healthy circumstances control and regulate the cell cycle; their change results in deregulation of cell division, acting at all cell, membrane,  cytoplasm, and nucleus levels.  Protein products of protooncogenes so-called. Oncoproteins regulate cell division, growth factors,  cellular receptors, other messengers, transcription factors, and cell division executors.

2.) Cancer – tumor suppressor genes encode proteins, inhibit the cell cycle, and participate in monitoring DNA damage repair.  The structure and function of suppressor genes are often lost or altered in cancer cells; loss of suppressor gene function is a typical occurrence in malignant/malignant cellular processes.

Protein products of suppressor genes are negative regulators of cell proliferation; loss of cancer-tumor cells’ expression leads to increased cell proliferation, which accelerates tumor development.  Cancer – tumor suppressor genes have an important function in cell differentiation that inhibits the cellular cycle, a prerequisite for normal cell differentiation.

Notes on the treatment of cancer – tumor – cancer – sarcoma – leukemia – lymphoma

A total of 95% of all people with cancer, tumors, cancer first go through aggressive official therapies medicine, which is understandable given the constant medical maintenance of psychosis of fear in public. However, far better treatment results with fewer or no side effects would have been achieved if the treatment started immediately with immune and metabolic therapies or a combination of conventional and natural/unconventional therapies. When the desired improvement does not occur, health condition or cure, and cancer cells progress. Metastases or secondary disease, which is a fact in almost all oncological diseases, then the affected persons decide to seek help within natural and unconventional medicine. More immunological and metabolic therapies represent a possible effective solution for healing from malignant/malignant tumors.

A patient with a cancer-weakened and conventional therapy-damaged organism should as soon as possible start building the immune system and bone marrow recovery. To give chances for a cure improved, it is necessary to strengthen the production and proliferation of immunogenic antibodies and antigens, T and B lymphocytes, NK cells, macrophages and phagocytes, the breakdown of connective tissue around cancer cells – tumors, acidic organism to make it alkaline again, to get rid of necrotic cells, toxins and mycotoxins from blood flow and lymph, stimulate cellular respiration and enhance ATP cellular energy production and  GTP.

When the bloodstream is flooded with toxins and dead tumor cells, deposition occurs in the bloodstream. Vessels, lungs, kidneys, or liver, cause swelling and inflammation of the organs, the formation of ascites and its outpouring into the abdomen or other places, and depends on the site of cancer.

The accumulation of ascites or free fluid (ammonia) is a consequence of the inability of the liver as the main immune system, to perform its function of cleansing the blood due to damage or clogging with toxins,  lactic acid, or the liver disease itself, which easily leads to septicemia or hepatic / heparin coma.

Infections, organ inflammation, pain, and ascites are the most common cancer patients’ complications and cause death in the vast majority of all cases of malignancies/malignancies.

Important note

It is unnecessary to abandon the official medical protocols to treat cancer – tumors – cancer. To man has benefited greatly from immunological and metabolic therapies and natural supplements; particularly, immunological and metabolic therapies and nutritional supplements are extremely effective. When used in combination with surgery, chemotherapy, and radiation, natural supplements have no harmful and toxic side effects on the body.

Immunological and metabolic therapies and nutritional supplements work in a way to support the body,  enhance the effectiveness of chemotherapy, radiation, and surgery in treatment, the immune system becomes much more powerful and effective in destroying and preventing the spread of cancer cells by the body, toxic the effects of chemotherapy and radiation. Their side effects are significantly weaker or completely reduced.

Immunological and metabolic therapies and natural nutritional supplements are in no contradiction with radiation, chemotherapy, and surgery; they do not cancel or reduce these therapies’ effects. On the contrary, it significantly increases their effectiveness.

If you look at cancer mortality statistics after going through official medical treatment and nevertheless do not apply immune and metabolic therapies and natural nutritional supplements in the fight against cancer, it is equal to the struggle for life and death with the decision that the struggle should take place with one hand tied to the back.

The fight against cancer is definitely a battle that does not want to be lost at any cost.

Treatment and recovery of the immune and metabolic system, and restoration of electrochemical cellular processes through the application of metabolic therapeutic treatment protocols

1.) Use of one or more tumor antagonists

2.) Proper antitumor diet or healthy diet

3.) Intake of essential macro and micronutrients

4.) Vitamins and minerals in a therapeutically higher and effective amount

5.) Enzymes and coenzymes, especially proteolysis enzymes, have the ability to degrade protein connective tissue that coats cancer cells and protects them from T and B lymphocytes and NK cells (large naturally killing cells, 1 NK cell can destroy up to 27 malignant cells by injecting into them cellular cytokine toxins).

6.) Light physical exercises with the help of which the blood is enriched with oxygen, which is important if we know that they are cancer cells are hypoxic and metabolically functional only in an environment free of oxygen and extra electrons and protons, which are released in the oxidative processes of converting glucose into energy. Intense exercise is not recommended because it leads the body to an additional lack of oxygen, for the body represents anaerobic stress, releases lactic acid from the muscles into the bloodstream, where the liver by the process of gluconeogenesis resynthesizes lactic acid back into glucose, which is a further context feeds malignant/malignant cells.

7.) Energy medicine is critical since cancer cells steal glucose from healthy cells due to the constant need for energy; for these reasons, one of the elementary problems in III, especially in stage IV of the disease, is a chronic lack of energy in the body the affected person.  By fermenting glucose into energy, the so-called rapid glycolysis cancer cells produce 15-20 times less  energy (about 5% ATP)) than normal healthy cells, but therefore have up to 8 times more glucose receptors.

Mitochondria are cellular organelles with their own DNA. They are responsible for ATP and  GTP cellular energy (mitochondria have from several hundred to several thousand in each cell).

A general problem for patients with stage IV cancer occurs when the body falls to a low level for a long energy level. It can no longer accumulate enough energy needed by healthy cells due to many glucose (energy) hungry cancer cells. The body begins a process medically known as Cachexia (Cachexia).

In the process of Cachexia, the liver must resynthesize large amounts of lactic acid, which is a waste the product of anaerobic cellular fermentation of pyruvate back into glucose (there is no need for intake nutrients, cancer cells feed themselves with the help of liver processes gluconeogenesis / Cory cycle, in this process the liver consumes about 40% of the energy needed by the body for normal cellular processes). During the active process of Cachexia, patients do not have a physiological need for nutrient intake.

Cachexia is the final stage in cancer patients. The body begins to feed on muscle tissue (large weight loss). Brain cells (symptoms are hallucinations), large amounts of lactic acid in the bloodstream causes organ inflammation and pain; interrupting the cachexia process is quite demanding.

The organism in the process of Cachexia literally dies of hunger and lack of life energy; without enough energy, the organism is not functionally capable of performing normal cellular processes.

Cachexia is fatal for about 65% of cancer patients – malignant/malignant tumors – cancers.

Energy treatments/therapies can interrupt the Cachexia process, especially in combination with certain anti-inflammatory supplements and liquid foods, leading to a decrease in lactic acid in the bloodstream and restarting digestion, the body’s need for macro and micronutrients.

Energy treatments have a strong effect on immunity, increase the energy of the whole organism, with their electromagnetic effect cause the rupture of cell membranes in the tumor and apoptosis of cells (fewer cancer cells mean less lactic acid in the bloodstream and less glucose, i.e., feed to cancer cells), and in this way, they lead to faster healing, for the reasons listed there is no further need to emphasize the usefulness and the purposefulness of energy medicine in the treatment of cancer – tumor – cancer.

8.) Daily stay in the sunlight and fresh air for a minimum of 60 minutes daily (should not be at once) is recommended to produce important vitamin D.

9.) Radiesthesia examination of the area where the sick person spends the most time is an important part of In the process of treating cancer – tumor – cancer, the practice has shown that until the cure of any disease difficult to come by if a person spends a lot of time under the influence of geopathogenic radiation (GPZ), a when the disease is cured or withdrawn, it often happens that after a certain period of time from remission, relapse or progression of the disease occurs again.

GPZ is electromagnetic radiation of the earth (groundwater, mineral veins, oil, substations, electrical lines, mob., tv, radio transmitters) or/and space, i.e., Hartmann – Cury nodes, radiation is always (+) or (-) ionically charged, if organism under long-term influence of radiation, regardless of whether (+) or (-) and what intensity, occurs electromagnetic imbalance in the body and electrochemical changes in cell structure and function.

10.) Detoxification of the organism is necessary and implies removing all toxic substances from close-range sick people, cessation of their use, and, if necessary, cleansing of toxins from the body itself.

11.) Anti-inflammatory supplements are an integral part of metabolic treatment since cancer – malignant/malignant tumors – cancer often leads to swelling of organs and infections. Such a condition is dangerous to patients’ lives.

12.) The spiritual-mental approach is important for the sick to gain confidence in their healing and maintenance of faith in the higher Self and adhere to all therapeutic protocols selected for their treatment.

Immunological and metabolic therapeutic protocols for the treatment of malignant cellular processes of cancer – tumor – cancer – sarcoma – leukemia – lymphoma

immune system and msm powder
Immune system cells

Immune therapy and metabolic treatment protocols have helped countless seriously ill people worldwide as a rule after a doctor has told them that medicine could do nothing for them anymore.

In the natural way of treating cancer – tumors – cancer by immune and metabolic therapies response  The body is generally not absent; however, reactions to treatment can be complete or partial.

Treatment with immune and metabolic therapeutic protocols has almost no side effects; it is easily tolerated and applied, and if combined with chemotherapy, radiation, and surgery, significantly increases the effectiveness of these therapies and eliminates many toxic side effects, strengthens immunity, and helps to destroy and prevent the spread of cancer cells, malignant/malignant tumors – cancer by the body.

Empirical facts  ;

Cancer is a systemic aggressor and malignant cellular process with more than 200 immune and metabolic disorders and symptoms, which symptomatically manifest as independent forms of the disease and in themselves dangerously endanger patients’ lives. Successful treatment requires a complete systemic approach and practical knowledge. To regain lost health!

There is currently no natural supplement, medical preparation, dietary supplement, or pharmaceutical drug that, as a stand-alone therapy, would be able to treat or cure cancer effectively.

Many known antitumor supplements, which in systemic treatment can help restore health, but on their own, do not have a sufficiently active and effective effect on the myriad immune and metabolic processes that occur in malignant/malignant cells!

Cancer – tumor – cancer is a complex immune, and metabolic disease and malignant disorder, which occurs at the genetic level of cellular, substantial and intercellular processes (DNA, RNA, proteins, enzymes, peptides), and only multidisciplinary approach and systemic treatment protocols can make the difference between cancer and a renewed health!

Official or conventional medicine has so far failed to find adequate therapeutic protocols, effective preparations or drugs for effective treatment and cure of cancer, malignant tumors, and turned to biomedicine, i.e., biochemical, molecular, and genetic research and newly set goals, how to turn cancer from aggressive systemic diseases into a chronic disease, it should be noted that for now, the goals set have remained on numerous attempts, with no significant results or advances in treatment.

“The doctor is not infallible, and therefore you must not be passive in accepting his opinion. It is about your future; you as a patient are most interested in it, you are the one who is interested in it it can gain the most, but also lose the most. If you as a patient can make decisions, you need to decide what a happy and meaningful life means to you. Don’t let a doctor, no matter how well-intentioned, seize that right. “

Dr. Eugene D. Robin (Matters of Life and Death)

Immunological and metabolic therapeutic protocols are used in the treatment of all types of malignant / malignant diseases / oncological diseases.

Treatment and therapy; breast cancer, bone cancer, brain cancer, bladder cancer, carcinoids, carcinoma, cervical cancer, colon cancer, squamous cell lung cancer, endometrial cancer, esophageal cancer, Hodgkin’s lymphoma, leukemia, kidney cancer and adrenal glands, liver cancer, melanoma, throat cancer, multiple myeloma, not Hodgkin’s lymphoma, non-small cell lung cancer, adenocarcinoma, osteosarcoma, medulloblastoma, astrocytoma, glioblastoma, oral cancer, ovarian cancer, pancreatic cancer, prostate cancer, rectal cancer, sarcoma, microcellular lung cancer, gastric cancer, testicular cancer, and cancer thymic carcinoids, urethral cancer, uterine cancer, vaginal cancer, thyroid cancer, bronchial cancer, duodenal cancer, plasmacytoma, etc.